Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Aug 16, 2022; 10(23): 8277-8283
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8277
Figure 2
Figure 2 Gadoxetic acid-enhanced liver magnetic resonance imaging. A: T2-weighted image; B: Before contrast; C: Arterial phase; D: Portal venous phase; E: Transitional phase; F: Hepatobiliary phase. Magnetic resonance images (MRIs) demonstrate a 4.5-cm mass (arrowhead) in S3. This mass presents subtle high signal intensity to adjacent hepatic parenchyma, peripheral rim enhancement during the arterial phase, and washout during the portal venous phase, transitional phase, and hepatobiliary phase. This mass was categorized using liver imaging reporting and data system M observations. MRIs demonstrate a 1.3-cm metastatic lymph (arrow) node along the common hepatic artery.